The arch conference declaration. Helping to further the science of pragmatic research

Martin R, Chisholm A, Price D

Ann Am Thorac Soc 2014; 11(Suppl 2): S83-4.

By |August 13th, 2013|OPCRD|0 Comments

Real-life comparison of beclometasone dipropionate as an extrafine- or larger-particle formulation for asthma

Price D, Thomas M, Haughney J, Lewis RA, Burden A, von Ziegenweidt J, Chisholm A, Hillyer EV, Corrigan CJ

Respir Med 2013; 107(7): 987-1000.

By |July 1st, 2013|OPCRD|0 Comments

A UK-based cost-utility analysis of indacaterol, a once-daily maintenance bronchodilator for patients with COPD, using real world evidence on resource use

Price D, Asukai Y, Ananthapavan J, Malcolm B, Radwan A, Keyzor I

Appl Health Econ Health Policy 2013; 11(3): 259-74.

By |January 1st, 2013|OPCRD|0 Comments

Effect of inhaled corticosteroid therapy step-down and dosing regimen on measures of asthma control

Price D, Chisholm A, Hillyer EV, Burden A, von Ziegenweidt J, Svedsater H, Dale P

J Aller Ther 2013; 4(1): 126.

By |January 1st, 2013|OPCRD|0 Comments

Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study

Price D, Lee A, Sims EJ, Kemp L, Hillyer EV, Chisholm A, von Ziegenweidt J, Williams, A

Prim Care Respir J 2013; 22(2): 161-8.

By |January 1st, 2013|OPCRD|0 Comments

Real-life asthma strategies: the missing piece in the jigsaw

Price D, Bjermer L, Haughney J, Roche N, Bousquet J, Hillyer EV, Chisholm A

Treatment Strategies – Respiratory 2012; 3(2): 37–46.

By |January 1st, 2012|OPCRD|0 Comments